Versarien (GB:VRS) has released an update.
Versarien PLC has signed a distribution agreement to bring innovative graphene-based biosensors, developed in South Korea, to the UK and European markets. These advanced sensors, featuring a novel graphene barristor technology, promise significant advancements in medical diagnostics by overcoming limitations of traditional graphene transistors. The collaboration is expected to expand with future developments in various sensor technologies.
For further insights into GB:VRS stock, check out TipRanks’ Stock Analysis page.